Neil Stahl - Dec 9, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/**Neil Stahl
Stock symbol
REGN
Transactions as of
Dec 9, 2022
Transactions value $
-$351,028
Form type
4
Date filed
12/13/2022, 03:11 PM
Previous filing
Aug 8, 2022
Next filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -330 -0.63% $0.00 52.5K Nov 8, 2022 Direct
transaction REGN Common Stock Tax liability -$351K -466 -0.89% $753.28 52K Dec 9, 2022 Direct
holding REGN Common Stock 5.81K Dec 9, 2022 By 401(k) Plan
holding REGN Common Stock 4.61K Dec 9, 2022 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.